Total Payments
$263,823
2024 Payments
$9,636
Companies
65
Transactions
1,475
Medicare Patients
3,659
Medicare Billing
$435,465
Payment Breakdown by Category
Other$190,343 (72.1%)
Food & Beverage$29,769 (11.3%)
Travel$21,689 (8.2%)
Consulting$21,478 (8.1%)
Education$543.90 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $190,343 | 96 | 72.1% |
| Food and Beverage | $29,769 | 1,277 | 11.3% |
| Travel and Lodging | $21,689 | 71 | 8.2% |
| Consulting Fee | $21,478 | 10 | 8.1% |
| Education | $543.90 | 21 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $132,384 | 248 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $34,661 | 121 | $0 (2024) |
| ABBVIE INC. | $33,913 | 271 | $0 (2024) |
| Allergan, Inc. | $16,721 | 77 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $12,308 | 15 | $0 (2020) |
| Amgen Inc. | $11,400 | 30 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $8,227 | 80 | $0 (2024) |
| LivaNova USA, Inc. | $2,607 | 27 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,804 | 48 | $0 (2022) |
| GENZYME CORPORATION | $973.36 | 55 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,636 | 169 | ABBVIE INC. ($6,643) |
| 2023 | $25,242 | 154 | EMD Serono, Inc. ($16,735) |
| 2022 | $36,148 | 202 | EMD Serono, Inc. ($21,539) |
| 2021 | $26,451 | 211 | AbbVie Inc. ($8,595) |
| 2020 | $32,353 | 173 | Allergan, Inc. ($13,180) |
| 2019 | $55,927 | 207 | EMD Serono, Inc. ($33,122) |
| 2018 | $36,633 | 183 | EMD Serono, Inc. ($21,253) |
| 2017 | $41,433 | 176 | EMD Serono, Inc. ($21,972) |
All Payment Transactions
1,475 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $39.89 | General |
| Category: Immunology and Neurology | ||||||
| 12/19/2024 | Abbott Laboratories | INFINITY (Device) | Travel and Lodging | In-kind items and services | $175.77 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Abbott Laboratories | INFINITY (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $148.32 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Neurology | ||||||
| 12/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| 12/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $1.42 | General |
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Neurology | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Neuromodulation | ||||||
| 11/25/2024 | EMD Serono, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $69.98 | General |
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $2.61 | General |
| 11/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.20 | General |
| 11/11/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 738 | 855 | $261,264 | $84,408 |
| 2022 | 11 | 888 | 1,039 | $329,741 | $110,496 |
| 2021 | 12 | 996 | 1,213 | $384,732 | $128,133 |
| 2020 | 11 | 1,037 | 1,280 | $385,463 | $112,428 |
Total Patients
3,659
Total Services
4,387
Medicare Billing
$435,465
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 262 | $46,636 | $16,337 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 178 | $46,814 | $16,143 | 34.5% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 41 | 41 | $40,836 | $13,512 | 33.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 98 | 180 | $40,500 | $13,474 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $31,600 | $9,634 | 30.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 39 | 39 | $19,071 | $5,147 | 27.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 24 | 24 | $15,552 | $4,653 | 29.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 29 | 29 | $16,936 | $4,499 | 26.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 23 | 23 | $3,319 | $1,009 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 229 | 276 | $72,588 | $25,338 | 34.9% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2022 | 60 | 60 | $59,760 | $19,627 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 254 | 272 | $48,416 | $17,692 | 36.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 102 | 185 | $41,625 | $14,819 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 112 | 112 | $44,800 | $14,410 | 32.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 44 | 44 | $25,696 | $7,386 | 28.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 33 | 33 | $16,137 | $4,722 | 29.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 11 | 11 | $7,128 | $2,208 | 31.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $6,060 | $1,995 | 32.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 11 | 12 | $4,440 | $1,312 | 29.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 20 | 22 | $3,091 | $987.14 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 344 | 411 | $73,158 | $25,900 | 35.4% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Office | 2021 | 71 | 72 | $71,712 | $23,331 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 177 | 219 | $57,597 | $20,670 | 35.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 134 | 134 | $53,600 | $17,043 | 31.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 95 | 194 | $43,650 | $15,422 | 35.3% |
About Dr. Aamir Rasheed, MD
Dr. Aamir Rasheed, MD is a Neurology healthcare provider based in Vestal, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568547933.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aamir Rasheed, MD has received a total of $263,823 in payments from pharmaceutical and medical device companies, with $9,636 received in 2024. These payments were reported across 1,475 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($190,343).
As a Medicare-enrolled provider, Rasheed has provided services to 3,659 Medicare beneficiaries, totaling 4,387 services with total Medicare billing of $435,465. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Vestal, NY
- Active Since 10/26/2006
- Last Updated 02/21/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1568547933
Products in Payments
- Rebif (Biological) $46,090
- UBRELVY (Drug) $36,945
- Mavenclad (Drug) $33,714
- Mavenclad (Biological) $30,228
- QULIPTA (Drug) $12,749
- Betaseron (Drug) $12,292
- MAVENCLAD (Drug) $11,563
- Aimovig (Biological) $11,275
- AJOVY (Biological) $10,480
- AJOVY (Drug) $10,188
- COPAXONE (Drug) $9,009
- MAYZENT (Drug) $4,985
- VNS Therapy (Device) $1,935
- APTIOM (Drug) $1,763
- ZEPOSIA (Drug) $718.22
- AUBAGIO (Drug) $657.75
- TYSABRI (Biological) $477.99
- VNS - Sentiva (Device) $474.38
- NURTEC ODT (Drug) $473.69
- BOTOX (Biological) $462.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.